These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12379255)

  • 1. Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl/6 mice: behavioural and histopathological characterisation.
    Fernagut PO; Diguet E; Stefanova N; Biran M; Wenning GK; Canioni P; Bioulac B; Tison F
    Neuroscience; 2002; 114(4):1005-17. PubMed ID: 12379255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: reference to striatonigral degeneration.
    Fernagut PO; Diguet E; Bioulac B; Tison F
    Exp Neurol; 2004 Jan; 185(1):47-62. PubMed ID: 14697318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.
    Guyot MC; Hantraye P; Dolan R; Palfi S; Maziére M; Brouillet E
    Neuroscience; 1997 Jul; 79(1):45-56. PubMed ID: 9178864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine transporter knock-out mice are hypersensitive to 3-nitropropionic acid-induced striatal damage.
    Fernagut PO; Diguet E; Jaber M; Bioulac B; Tison F
    Eur J Neurosci; 2002 Jun; 15(12):2053-6. PubMed ID: 12099912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin is neuroprotective in a transgenic mouse model of multiple system atrophy.
    Köllensperger M; Krismer F; Pallua A; Stefanova N; Poewe W; Wenning GK
    Mov Disord; 2011 Feb; 26(3):507-515. PubMed ID: 21462262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple method to measure stride length as an index of nigrostriatal dysfunction in mice.
    Fernagut PO; Diguet E; Labattu B; Tison F
    J Neurosci Methods; 2002 Jan; 113(2):123-30. PubMed ID: 11772434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats.
    Guyot MC; Palfi S; Stutzmann JM; Mazière M; Hantraye P; Brouillet E
    Neuroscience; 1997 Nov; 81(1):141-9. PubMed ID: 9300407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No functional effects of embryonic neuronal grafts on motor deficits in a 3-nitropropionic acid rat model of advanced striatonigral degeneration (multiple system atrophy).
    Waldner R; Puschban Z; Scherfler C; Seppi K; Jellinger K; Poewe W; Wenning GK
    Neuroscience; 2001; 102(3):581-92. PubMed ID: 11226695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of alpha-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid.
    Nakao N; Brundin P
    Neuroscience; 1997 Feb; 76(3):749-61. PubMed ID: 9135048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor behaviour deficits and their histopathological and functional correlates in the nigrostriatal system of dopamine transporter knockout mice.
    Fernagut PO; Chalon S; Diguet E; Guilloteau D; Tison F; Jaber M
    Neuroscience; 2003; 116(4):1123-30. PubMed ID: 12617953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dystonia is predictive of subsequent altered dopaminergic responsiveness in a chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine+3-nitropropionic acid model of striatonigral degeneration in monkeys.
    Ghorayeb I; Fernagut PO; Stefanova N; Wenning GK; Bioulac B; Tison F
    Neurosci Lett; 2002 Dec; 335(1):34-8. PubMed ID: 12457736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glial cell line-derived neurotrophic factor attenuates the locomotor hypofunction and striatonigral neurochemical deficits induced by chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid.
    Araujo DM; Hilt DC
    Neuroscience; 1998 Jan; 82(1):117-27. PubMed ID: 9483508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined treatment with C16 peptide and angiopoietin-1 confers neuroprotection and reduces inflammation in 3-nitropropionic acid-induced dystonia mice.
    Fu XX; Cai HY; Jiang H; Han S
    Aging (Albany NY); 2021 Jul; 13(14):19048-19063. PubMed ID: 34326273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased striatal dopamine release underlies increased expression of long-term synaptic potentiation at corticostriatal synapses 24 h after 3-nitropropionic-acid-induced chemical hypoxia.
    Akopian G; Crawford C; Beal MF; Cappelletti M; Jakowec MW; Petzinger GM; Zheng L; Gheorghe SL; Reichel CM; Chow R; Walsh JP
    J Neurosci; 2008 Sep; 28(38):9585-97. PubMed ID: 18799690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of systemic 3-nitropropionic acid-induced lesions of the dorsal striatum on cannabinoid and mu-opioid receptor binding in the basal ganglia.
    Page KJ; Besret L; Jain M; Monaghan EM; Dunnett SB; Everitt BJ
    Exp Brain Res; 2000 Jan; 130(2):142-50. PubMed ID: 10672467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal dopamine depletion and behavioural sensitization induced by methamphetamine and 3-nitropropionic acid.
    Eradiri OL; Starr MS
    Eur J Pharmacol; 1999 Dec; 386(2-3):217-26. PubMed ID: 10618473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies.
    Ouary S; Bizat N; Altairac S; Ménétrat H; Mittoux V; Condé F; Hantraye P; Brouillet E
    Neuroscience; 2000; 97(3):521-30. PubMed ID: 10828534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of riluzole on combined MPTP + 3-nitropropionic acid-induced mild to moderate striatonigral degeneration in mice.
    Diguet E; Fernagut PO; Scherfler C; Wenning G; Tison F
    J Neural Transm (Vienna); 2005 May; 112(5):613-31. PubMed ID: 15503195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration.
    Ghorayeb I; Fernagut PO; Aubert I; Bezard E; Poewe W; Wenning GK; Tison F
    Mov Disord; 2000 May; 15(3):531-6. PubMed ID: 10830420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrapyramidal motor symptoms versus striatal infarction volume after focal ischemia in mongolian gerbils.
    Ishibashi S; Kuroiwa T; Katsumata N; Yuan SL; Endo S; Mizusawa H
    Neuroscience; 2004; 127(2):269-75. PubMed ID: 15262318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.